Bimzelx (bimekizumab-bkzx) - UCB
Humira (adalimumab) - AbbVie
Tremfya (guselkumab) - J&J
Cosentyx (secukinumab) - Novartis
Stelara (ustekinumab) - J&J
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
http://www.ncbi.nlm.nih.gov/pubmed/42181314
 
Abdullah Abdullah; Linda Polus
 
May 26, 2026
 
Prev Next